ipilimumab,nivolumab
bms
['renal,(-adrenal)']
a randomized phase 1 trial in treatment-naive patients with metastatic #renalcellcarcinoma shows that a live bacterial product + #immunotherapy combination elicits promising clinical benefit #aacr23 #earlyphasetrial 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.